Pfizer

  • Gelfoam 2014 report

    Gelfoam 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 33 Pages The 5 Key Questions Addressed by this...

  • Genotropin 2014 report

    Genotropin 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Inlyta 2014 report

    Inlyta 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Lyrica 2014 report

    Lyrica 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 31 Pages The 5 Key Questions Addressed by this...

  • Premarin 2014 report

    Premarin 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Prevnar 13 2014 report

    Prevnar 13 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 27 Pages The 5 Key Questions Addressed by...

  • Pristiq 2014 report

    Pristiq 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Quillivant XR 2014 report

    Quillivant XR 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by...

  • Rebif 2014 report

    Rebif 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 18 Pages The 5 Key Questions Addressed by this...

  • Relpax 2014 report

    Relpax 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Somavert 2014 report

    Somavert 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Sutent 2014 report

    Sutent 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...